Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
28,654,397
Share change
-1,028,322
Total reported value
$97,285,032
Put/Call ratio
236%
Price per share
$3.40
Number of holders
100
Value change
-$6,579,840
Number of buys
35
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2023

As of 31 Mar 2023, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,654,397 shares. The largest 10 holders included CAS Investment Partners, LLC, BlackRock Inc., 683 Capital Management, LLC, VANGUARD GROUP INC, General Equity Holdings LP, BAILLIE GIFFORD & CO, KPS Global Asset Management UK Ltd, D. E. Shaw & Co., Inc., MARSHALL WACE, LLP, and WORLDLY PARTNERS MANAGEMENT, LLC. This page lists 100 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.